Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
Newsom-Davis
J
J
Department of Neurological Science, Royal Free Hospital School of Medicine, London, England.
Willcox
N
N
Schluep
M
M
Harcourt
G
G
Vincent
A
A
Mossman
S
S
Wray
D
D
Burges
J
J
D000367:Age Factors; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D006801:Humans; D006965:Hyperplasia; D007111:Immunity, Cellular; D051379:Mice; D009157:Myasthenia Gravis / Q000145:classification / Q000276:immunology* / Q000473:pathology; D009469:Neuromuscular Junction / Q000276:immunology; D011978:Receptors, Nicotinic / Q000276:immunology; D009435:Synaptic Transmission; D013945:Thymoma / Q000150:complications; D013950:Thymus Gland / Q000473:pathology; D013953:Thymus Neoplasms / Q000150:complications
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D011978:Receptors, Nicotinic